DekaBank Deutsche Girozentrale’s PTC Therapeutics PTCT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.62M	Hold	24,000	–	–	﹤0.01%	728
2026 Q1	$1.66M	Hold	24,000	–	–	﹤0.01%	728
2025 Q4	$768K	Hold	24,000	–	–	﹤0.01%	928
2025 Q3	$1.44M	Hold	24,000	–	–	﹤0.01%	811
2025 Q2	$1.19M	Hold	24,000	–	–	﹤0.01%	828
2025 Q1	$1.28M	Hold	24,000	–	–	﹤0.01%	806
2024 Q4	$1.07M	Hold	24,000	–	–	﹤0.01%	865
2024 Q3	$889K	Sell	24,000 -5,016	-17%	-$168K	﹤0.01%	912
2024 Q2	$995K	Buy	29,016 +5,016	+21%	+$162K	﹤0.01%	880
2024 Q1	$695K	Hold	24,000	–	–	﹤0.01%	943
2023 Q4	$673K	Sell	24,000 -3,976	-14%	-$90.9K	﹤0.01%	976
2023 Q3	$622K	Buy	27,976 +3,976	+17%	+$148K	﹤0.01%	969
2023 Q2	$964K	Hold	24,000	–	–	﹤0.01%	889
2023 Q1	$1.16M	Hold	24,000	–	–	﹤0.01%	838
2022 Q4	$881K	Hold	24,000	–	–	﹤0.01%	909
2022 Q3	$1.2M	Buy	24,000 +7,200	+43%	+$353K	﹤0.01%	829
2022 Q2	$667K	Hold	16,800	–	–	﹤0.01%	967
2022 Q1	$627K	Buy	16,800 +1,500	+10%	+$57.8K	﹤0.01%	1016
2021 Q4	$614K	Buy	15,300 +400	+3%	+$15.3K	﹤0.01%	1050
2021 Q3	$549K	Hold	14,900	–	–	﹤0.01%	1028
2021 Q2	$618K	Hold	14,900	–	–	﹤0.01%	1024
2021 Q1	$690K	Sell	14,900 -7,000	-32%	-$416K	﹤0.01%	974
2020 Q4	$1.4M	Sell	21,900 -33,100	-60%	-$1.95M	0.01%	763
2020 Q3	$2.57M	Buy	+55,000	New	+$2.71M	0.01%	542

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

DekaBank Deutsche Girozentrale's PTCT Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 24,000 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #728.

DekaBank Deutsche Girozentrale first reported a position in PTCT in Q3 2020 and has held it in 24 quarters since. The position peaked at $2.57M in Q3 2020. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

DekaBank Deutsche Girozentrale held 24,000 shares of PTC Therapeutics worth $1.62M as of Q2 2026.
DekaBank Deutsche Girozentrale left its PTC Therapeutics share count unchanged in Q2 2026.
PTC Therapeutics made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #728 holding.
DekaBank Deutsche Girozentrale first reported a position in PTC Therapeutics in Q3 2020 and has held it in 24 quarters since.
DekaBank Deutsche Girozentrale's PTC Therapeutics position peaked at $2.57M in Q3 2020.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.